We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to use a cost utility analysis to evaluate your digital health product.
If you’re travelling abroad, it's important to take out appropriate travel insurance before you go.
Following its Phase 1 investigation, the CMA has found that Theramex's proposed purchase of Femoston and Duphaston could reduce competition and choice for hormone replacement therapy treatments.
How to use a cost benefit analysis to evaluate your digital health product.
How to use a cost effectiveness analysis to evaluate your digital health product.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Read about talking therapies and counselling for mental health problems.
What you need to know before you can place a medical device on the Great Britain market with a UKCA mark.
An approach to payment for providers of IAPT services that links payment to patient outcomes as well as the provider’s levels of activity.
How to use a cost consequence analysis to evaluate your digital health product.
Added to community-based treatment of severe acute malnutrition in Sindh Province, Pakistan
Evaluates a range of monitoring strategies, including clinical, CD4 cell count and viral load monitoring
Information for British people on medical support in Thailand including mental health, lists of hospitals and care homes and how the British embassy can help.
Tax and reporting rules for employers providing medical or dental treatment and insurance
How to get a marketing authorisation for an Advanced Therapy Medicinal Product (ATMP) so it can be sold and/or supplied in Great Britain.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).